Litcius/Paper detail

Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency

Luís Eduardo Ribeiro da Cunha, Adilson A. Stolet, Marcelo A. Strauch, Victor A. R. Pereira, Carlos H. Dumard, Andre M.O. Gomes, Fábio Luís Lima Monteiro, Luiza M. Higa, Patrícia N. C. Souza, Juliana Garcia da Silva Fonseca, Francisco Eduardo de Pontes, Leonardo G. R. Meirelles, José W. M. Albuquerque, Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Túlio M. Lima, Renata G. F. Alvim, Federico F. Marsili, Marcella Moreira Caldeira, Russolina B. Zingali, Guilherme A. P. de Oliveira, Thiago Moreno L. Souza, Alexandre dos Santos da Silva, Rodrigo Müller, Daniela del Rosário Flores Rodrigues, Luciana Jesus da Costa, Arthur Daniel Rocha Alves, Marcelo Alves Pinto, Andréa C. Oliveira, Herbert Leonel de Matos Guedes, Amílcar Tanuri, Leda R. Castilho, Jerson L. Silva

2021iScience35 citationsDOIOpen Access PDF

Abstract

preparation for the clinical treatment of COVID patients.

Topics & Concepts

TiterPolyclonal antibodiesNeutralizationAntibodyVirologyRecombinant DNANeutralizing antibodySpike ProteinConvalescent plasmaMolecular biologyGlycoproteinChemistryAntibody titerCoronavirus disease 2019 (COVID-19)ImmunologyMedicineBiologyBiochemistryInternal medicineInfectious disease (medical specialty)GeneDiseaseSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral gastroenteritis research and epidemiology
Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency | Litcius